MedTrace Logo

Effects of Structural Integration on Chest Wall Expansion Among COPD Patients

NCT07752420 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-08-07

No results posted yet for this study

Summary

The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.

Conditions

  • COPD (With - Without Rehabilitation)

Interventions

OTHER

Structural Integration with Conventional Pulmonary Rehabilitation

* Conventional pulmonary rehabilitation. * The complete 10-Series of Structural Integration, delivered by a certified Structural Integration practitioner/physiotherapist.

OTHER

Pulmonary Rehabilitation only

Participants receive only the conventional pulmonary rehabilitation program.

Sponsors & Collaborators

  • Green International University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2026-11-15
Completion
2026-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07752420 on ClinicalTrials.gov